The Protective Role of Telmisartan Against Nephrotoxicity Induced by X-ray Contrast Media in Rat Model

References

• Fishman EK, Reddan D. What are radiologists doing to prevent contrast-induced nephropathy compared with measures supported by current evidence? A survey of European radiologists on RCIN associated with computed tomography. Acta Radiol 2008; 49: 310–20
   PubMed Web of Science ®Google Scholar
• Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ 2005; 172: 1461–71
   PubMed Web of Science ®Google Scholar
• Thomsen HS, Morcos SK, Barrett BJ. Contrast-induced nephropathy: the wheel has turned 360 degrees. Acta Radiol 2008; 49: 646–57
   PubMed Web of Science ®Google Scholar
• Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Lundkvist J. Cost-effectiveness of iodixanol in patients at high risk of contrast induced nephropathy. Am Heart J 2005; 149: 298–303
   PubMed Web of Science ®Google Scholar
• Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxicity in high-risk patients study of iso-osmolar and low osmolar non-ionic contrast media study investigators: nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003; 348: 491–9
   PubMed Web of Science ®Google Scholar
• Katzberg RW. Contrast media-induced nephrotoxicity: which pathway?. Radiology 2005; 235: 752–5
   PubMed Web of Science ®Google Scholar
• Maeder M, Klein M, Fehr T, Rickli H. Contrast nephropathy: review focusing on prevention. J Am Coll Cardiol 2004; 44: 1763–71
   PubMed Web of Science ®Google Scholar
• Duan SB, Liu FY, Luo JA, Wu HW, Liu RH, Peng YM, et al. Nephrotoxicity of high- and low-osmolar contrast media. The protective role of amlodipine in a rat model. Acta Radiol 2000; 41: 503–7
   PubMed Web of Science ®Google Scholar
• Briguori C, Airoldi F, Morici N, Colombo A. New pharmacological protocols to prevent or reduce contrast media nephropathy. Minerva Cardioangiol 2005; 53: 49–58
   PubMedGoogle Scholar
• Russo D, Minutolo R, Cianciaruso B, Memoli B, Conte G, De Nicola L. Early effect of contrast media on renal hemodynamics tubular function in chronic renal failure. J Am Soc Nephrol 1995; 6: 1451–8
   PubMed Web of Science ®Google Scholar
• Yang D, Jia RH, Yang DP, Ding GH, Huang CX. Dietary hypercholesterolemia aggravates contrast media-induced nephropathy. Chin Med J 2004; 117: 542–6
   PubMed Web of Science ®Google Scholar
• Gupta RK, Kapoor A, Tewari S, Sinha N, Sharma RK. Captopril for prevention of contrast-induced nephropathy in diabetic patients: a randomised study. Indian Heart J 1999; 51: 521–6
   PubMedGoogle Scholar
• Rosenstock JL, Bruno R, Kim JK, Lubarsky L, Schaller R, Panagopoulos G, et al. The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy. Int Urol Nephrol 2008; 40: 749–55
   PubMed Web of Science ®Google Scholar
• Shoda J, Kanno Y, Suzuki H. A five-year comparison of the renal protective effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with non-diabetic nephropathy. Intern Med 2006; 45: 193–8
   PubMed Web of Science ®Google Scholar
• Battershill AJ, Scott LJ. Telmisartan: a review of its use in the management of hypertension. Drugs 2006; 66: 51–83
   PubMed Web of Science ®Google Scholar
• Duan SB, Zhou XR, Liu FY, Peng YM, Chen YY, Pei YY, et al. Comparative cytotoxicity of high-osmolar and low-osmolar contrast media on HKC in vitro. J Nephrol 2006; 19: 717–24
   PubMed Web of Science ®Google Scholar
• Dlamini A, Mbita Z, Zungu M. Genealogy, expression, and molecular mechanisms in apoptosis. Pharmacol Ther 2004; 101: 1–15
   PubMed Web of Science ®Google Scholar
• Haller C, Hizoh I. The cytotoxicity of iodinated radiocontrast agents on renal cells in vitro. Invest Radiol 2004; 39: 149–54
   PubMed Web of Science ®Google Scholar
• Schick CS, Haller C. Comparative cytotoxicity of ionic and nonionic radiocontrast agents on MDCK cell monolayers in vitro. Nephrol Dial Transplant 1999; 14: 342–7
   PubMed Web of Science ®Google Scholar
• Peer A, Averbukh Z, Berman S, Modai D, Averbukh M, Weissgarten J. Contrast media augmented apoptosis of cultured renal mesangial, tubular, epithelial, and hepatic cell. Invest Radiol 2003; 38: 177–82
   PubMed Web of Science ®Google Scholar
• Cunha MA, Schor N. Effects of gentamicin, lipopolysaccharide, and contrast media on immortalized proximal tubular cells. Ren Fail 2002; 24: 687–90
   PubMed Web of Science ®Google Scholar
• Kaushal GP, Kaushal V, Hong X, Shah SV. Role and regulation of activation of caspases in cisplatin induced injury to renal tubular epithelial cell. Kidney Int 2001; 60: 1726–36
   PubMed Web of Science ®Google Scholar
• Wong VY, Keller PM, Nuttall ME, Kikly K, DeWolf WE, Jr, Lee D, et al. Role of caspases in human renal proximal tubular epithelial cell apoptosis. Eur J Pharmacol 2001; 433: 135–40
   PubMed Web of Science ®Google Scholar
• Soejima K, Uozumi J, Kanou T, Fujiyama C, Masaki Z. Nonionic contrast media are less nephrotoxic than ionic contrast media to rat renal cortical slics. Toxicol Lett 2003; 143: 17–25
   PubMed Web of Science ®Google Scholar
• From AM, Bartholmai BJ, Williams AW, McDonald FS. Iodixanol compared to iohexol for contrast procedures: a case-matched retrospective cohort study. Acta Radiol 2008; 49: 409–14
   PubMed Web of Science ®Google Scholar
• Heyman SN, Rosen S, Rosenberger C. Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy. Clin J Am Soc Nephrol 2008; 3: 288–96
   PubMed Web of Science ®Google Scholar
• Cibulskyte D, Pedersen M, Horlyck A, Marcussen N, Hansen HE, Frøkiær J. Telmisartan attenuates chronic cyclosporin A nephrotoxicity in a pig model. Nephrol Dial Transplant 2007; 22: 369–75
   PubMed Web of Science ®Google Scholar
• Ruilope LM, Redón J, Schmieder R. Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from The ONTARGET Trial Programme. Vasc Health Risk Manag 2007; 3: 1–9
   PubMedGoogle Scholar